Kiniksa Pharmaceuticals International, plc (KNSA)

KNSA Revenue by Segment

Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Product	365.71M	318.30M	269.40M	233.18M	201.90M	170.52M	142.99M	122.52M
Product Growth	81.14%	86.67%	88.40%	90.31%	99.25%	113.14%	135.45%	217.88%
License and Collaboration	-	20.63M	32.37M	37.08M	46.85M	110.32M	93.34M	97.66M
License and Collaboration Growth	-	-81.30%	-65.32%	-62.03%	-38.12%	-	833.42%	-

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.